Digital Medicine Society Releases Digital Measures Set for Mental Health Disorders

June 05, 2026
The Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) has introduced the first digital measures set designed for common mental health disorders. The release provides standardized tools for researchers, clinicians, and developers to assess treatment effects and patient outcomes using sensor-based data.

The Digital Health Measurement Collaborative Community (DATAcc) by Digital Medicine Society has released the Digital Measures Set for Common Mental Health Disorders, announced in a press release. The set is the first of its kind developed specifically for common mental health conditions and was created with input from more than 20 partners across industry, advocacy, and research.

The resource provides a standardized foundation for measuring symptoms and treatment effects using digital health technologies. It includes seven validated measures covering sleep, physical activity, daily routine variability, cognitive function, speech and language changes, autonomic function, and facial and gaze features. These measures are intended for use in clinical trials and healthcare delivery to capture real-world patient experiences.

The set helps researchers and clinicians apply continuous, sensor-based data to better characterize patients and evaluate treatment effectiveness between visits. It also identifies areas where new measures are needed to support future development. The work builds on DiMe’s prior initiatives to advance sensor-based digital health technologies and supports the shift toward outcomes-based approaches in behavioral and mental healthcare.

Participating organizations include the American Psychological Association, BetterHelp, Compass Pathways, the FDA, MindMed, Otsuka, and Talkspace, among others.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more